Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin gets seven USFDA observations for Goa facility

Cohance Lifesciences Nacharam facility gets OAI status from USFDA

Ruchika Sharma27 Oct 2025 11:38 AM IST

Mumbai: Cohance Lifesciences has announced that the Company has received report from the United States Food and Drug Administration (USFDA),...

Novo Nordisk gets UK nod for Concizumab to prevent bleeding episodes frequency

Novo Nordisk gets MHRA nod for Concizumab to prevent bleeding episodes frequency

Ruchika Sharma27 Oct 2025 10:30 AM IST

Novo Nordisk has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for the medicine concizumab (brand name:...

Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case

Moderna scraps mRNA vaccine in congenital CMV on trial failure

Ruchika Sharma26 Oct 2025 4:45 PM IST

Cambridge: Moderna, Inc. has announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company's...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche appoints Nina Schwab-Hautzinger as Head of Group Communications

Ruchika Sharma26 Oct 2025 2:45 PM IST

Basel: Roche has announced that Nina Schwab-Hautzinger has been appointed Head of Group Communications and a member of the enlarged Corporate...

Lilly to buy Adverum Biotechnologies

Ruchika Sharma26 Oct 2025 1:30 PM IST

Indianapolis: Eli Lilly and Company and Adverum Biotechnologies, Inc., a clinical-stage company, have announced a definitive agreement...

Dr Reddy's Labs assigns additional responsibilities of CHRO office to Sanjay Sharma

Ruchika Sharma26 Oct 2025 1:00 PM IST

Dr Reddy's Labs has announced that the Board of Directors of the Company has assigned additional responsibilities of the Chief Human Resources...

Syngene International plans to add bioconjugation suite for end-to-end Antibody-Drug conjugates development

Ruchika Sharma25 Oct 2025 5:30 PM IST

Mumbai: Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP...

Merck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev for bladder cancer

Ruchika Sharma25 Oct 2025 3:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has...

Zydus-owned Sentynls Menkes disease drug NDA resubmission accepted by USFDA

Zydus bags Health Canada approval for Mesalamine suppositories for active ulcerative proctitis

Ruchika Sharma25 Oct 2025 12:36 PM IST

Ahmedabad: Zydus Lifesciences Limited has received NOC (Notice of Compliance) from Health Canada for generic Mesalamine suppositories 1000 ...

Bayer new drug application for gadoquatrane accepted for review in China

Bayer Lynkuet gets USFDA nod for treatment of moderate to severe vasomotor symptoms due to menopause

Ruchika Sharma25 Oct 2025 11:30 AM IST

Berlin: Bayer has received approval for elinzanetant from the U.S. Food and Drug Administration (FDA) as the dual neurokinin (NK)...

MP FDA Moves Rs 320-Crore Proposal to CDSCO, FSSAI to Upgrade Drug, Food Testing Labs

Telangana: Medical shop seized, licence cancelled for illegal sale of Schedule H1 drugs

Ruchika Sharma24 Oct 2025 5:24 PM IST

Telangana: A medical shop has been seized and its medical licence cancelled in Telangana for illegally selling Schedule H1 drugs (Spasmo-Proxyvon Plus...

Aurobindo Pharma arm Eugia Pharma B.V incorporates new wholly owned subsidiary in Chile

Aurobindo Pharma arm Eugia Pharma B.V incorporates wholly owned subsidiary in Chile

Ruchika Sharma24 Oct 2025 4:20 PM IST

Hyderabad: Aurobindo Pharma Limited has announced that Eugia Pharma B.V, a wholly owned stepdown subsidiary of the Company, has ...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok